Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03353415 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03353415 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 26 participants.
The verdict
NCT03353415, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the use of a continuous glucose monitor (CGM) by people who experience low blood sugars (hypoglycemia) after gastric surgery can help reduce the number and severity of low blood sugar episodes.
Interventions
- DEVICE Dexcom CGM masked
- DEVICE Dexcom CGM unmasked
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2023-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03353415
The ClinicalTrials.gov registry entry for NCT03353415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom CGM masked is the first listed.
NCT03353415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03353415 about?
NCT03353415 is a clinical study titled "Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery". The purpose of this study is to see if the use of a continuous glucose monitor (CGM) by people who experience low blood sugars (hypoglycemia) after gastric surgery can help reduce the number and severity of low blood sugar episodes.
What is the current status of trial NCT03353415?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-02-07. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT03353415?
The interventions under investigation include: Dexcom CGM masked (DEVICE), Dexcom CGM unmasked (DEVICE).
Who is sponsoring clinical trial NCT03353415?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.